组蛋白去乙酰化酶抑制剂通过抑制缺氧诱导因子-1α诱导的基质金属蛋白酶9过表达保护失血性休克中的内皮糖萼
本研究构建大鼠失血性休克模型与人脐静脉内皮细胞糖氧剥夺模型,比较组蛋白去乙酰化酶抑制剂 Tub A 与 VPA 对内皮糖萼脱落的保护作用及机制。失血性休克后肺毛细血管通透性与内皮糖萼脱落显著增加;Tub A 与 VPA 均降低肺毛细血管通透性、抑制内皮糖萼降解、下调 HIF-1α 与 MMP-9 表达,且 Tub A 效果优于 VPA。体外研究提示 Tub A 通过抑制 HIF-1α 诱导的 MMP-9 过表达保护内皮糖萼。作者认为 Tub A 是保护失血性休克时血管完整性的有前景的治疗候选物。
要点
- 大鼠失血性休克后肺毛细血管通透性与内皮糖萼脱落显著增加。
- Tub A 与 VPA 均降低失血性休克大鼠肺毛细血管通透性、抑制内皮糖萼降解。
- Tub A 与 VPA 均下调失血性休克大鼠 HIF-1α 与 MMP-9 表达,Tub A 效果优于 VPA。
- 体外实验提示 Tub A 通过抑制 HIF-1α 诱导的 MMP-9 过表达减轻内皮糖萼降解。
- 作者认为 Tub A 是失血性休克时保护血管完整性的有前景的治疗候选物。
适用人群与场景
- 大鼠失血性休克模型与人脐静脉内皮细胞糖氧剥夺模型(基础研究,非临床人群)。
研究设计与关键结果
- 研究类型为大鼠失血性休克模型与人脐静脉内皮细胞糖氧剥夺模型的对照实验研究。
- 失血性休克后肺毛细血管通透性与内皮糖萼脱落显著增加。
- Tub A 与 VPA 均降低失血性休克大鼠肺毛细血管通透性、抑制内皮糖萼降解、下调 HIF-1α 与 MMP-9 表达,且 Tub A 效果优于 VPA。
- 体外研究提示 Tub A 通过抑制 HIF-1α 诱导的 MMP-9 过表达保护内皮糖萼。
证据类型、等级与局限
- 证据类型:动物实验与体外细胞实验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hemorrhagic shock (HS) induces severe vascular leakage, often resulting in multiple organ dysfunction, making it a critical medical challenge. The vascular endothelial glycocalyx (vEG), which covers the endothelial surface of the blood vessels, plays a critical role in maintaining the vascular barrier function. Protection of vEG offers novel therapeutic opportunities to improve clinical symptoms in patients with HS. Valproic acid (VPA) and tubastatin A (Tub A), as histone deacetylase inhibitors, have been found to have strong prosurvival effects in animal models with HS, but their impact on the shedding of vEG is still unknown during HS. The purpose of this study is to determine the comparative therapeutic effects of Tub A and VPA in protecting vEG during HS by suppressing hypoxia-inducible factor-1α (HIF-1α)/matrix metalloproteinase 9 (MMP-9) signaling.
METHODS: This study constructed rat models of HS and human umbilical vein endothelial cell models of glucose-oxygen deprivation and conducted comparative studies on the protective effects and mechanisms of Tub A and VPA on vEG shedding induced by HS, thereby improving vascular leakage.
RESULTS: Pulmonary-capillary permeability and the shedding of vEG were significantly increased after HS. Tub A and VPA reduced pulmonary-capillary permeability, inhibited the degradation of vEG, and downregulated the expression of HIF-1α and MMP-9 in rats with HS, and the effect of Tub A is better than VPA. Further in vitro investigations indicated that Tub A protected against endothelial glycocalyx degradation by suppressing HIF-1α-induced overexpression of MMP-9.
CONCLUSION: Tub A attenuates the increased vascular permeability induced by HS by protecting vEG via inhibiting HIF-1α/MMP-9 signaling, with superior effects over VPA. These results highlight Tub A as a promising therapeutic candidate for protecting vascular integrity during HS.
参考来源
- Zhang Y, Zhang Z, Chi Y, et al. Histone deacetylase inhibitors protect endothelial glycocalyx via suppressing hypoxia-inducible factor-1α-induced overexpression of matrix metalloproteinase 9 during hemorrhagic shock. J Trauma Acute Care Surg. 2025. PMID: 40956306. doi:10.1097/TA.0000000000004767
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。